working

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Hardman & Co Monthly: January 2025

Companies: SYGGF INDVN 4BB ACSO PRM SUN AMS ARBB SN/ EKF EAH SAR TSTL IPO HAT CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC APAX AREC ONT SLN IMCR ABDX

N+1 Singer - Silence Therapeutics - Successful Capital Markets Day highlighting the broad utility of GalNAc

Companies: Silence Therapeutics plc

Hardman & Co Healthcare Index: 2024 – Tough year for Life Sciences

Companies: TXG SYGGF INDVN Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX

Funding secured for Phase IIb trial

Companies: Verona Pharma plc Sponsored ADR

Synairgen CEO on funding critical Phase 2 trial for SNG001

Companies: Synairgen plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top